Upexi UPXI Purchase Price Receivable Vitamedica Current
Purchase Price Receivable Vitamedica Current at other companies
Other financials
Where this comes from
Reported directly by Upexi in its filing.
Tagged under the XBRL concept upxi:PurchasePriceReceivableVitamedicaCurrent.
The official record: Upexi’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upexi's purchase price receivable vitamedica current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upexi's purchase price receivable vitamedica current?
- Upexi (UPXI) reported purchase price receivable vitamedica current of $1.34M in Q1 2026.
- How has Upexi's purchase price receivable vitamedica current changed year-over-year?
- Upexi's purchase price receivable vitamedica current decreased by 33.0% year-over-year, from $2M to $1.34M.
- What does purchase price receivable vitamedica current mean?
- This represents the current portion of receivables arising from the divestiture or adjustment of the Vitamedica business unit. It indicates cash expected to be collected from the counterparty within the next twelve months as part of the acquisition or sale agreement. Tracking this is essential for understanding short-term cash inflows related to corporate restructuring activities.